Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003157	mm-hygvi	— (—)	94	616	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Postpartum care and examination

+∞

25.19

7.4

0.0

—

False labour

10.19

23.55

5.7

6.9

—

Antenatal screening

+∞

18.90

7.3

0.0

—

Supervision of high-risk pregnancy

+∞

16.96

8.4

0.0

—

Persons encountering health services in circumstances related to reproduction

+∞

16.04

8.1

0.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

7.43

15.79

6.7

6.5

—

Single spontaneous delivery

26.64

15.23

7.0

5.2

—

Other maternal disorders predominantly related to pregnancy

5.00

13.99

6.3

7.0

—

Maternal care for other known or suspected fetal problems

7.34

13.56

6.0

6.9

—

Delivery

23.29

13.02

7.7

5.2

—

Outcome of delivery

+∞

12.86

8.1

0.0

—

Pregnancy examination and test

+∞

12.04

6.4

0.0

—

Supervision of normal pregnancy

+∞

11.58

6.1

0.0

—

Contraceptive management

+∞

8.14

6.6

0.0

—

Diabetes mellitus in pregnancy

3.77

7.41

4.8

7.1

—

Procreative management

+∞

6.82

6.3

0.0

—

Other disorders of amniotic fluid and membranes

6.42

6.69

5.9

7.2

—

Complications of labour and delivery

3.37

6.31

8.0

5.3

—

Labour and delivery complicated by fetal stress [distress]

3.61

5.69

7.6

5.4

—

Premature rupture of membranes

5.03

5.63

6.8

6.7

—

Maternal care for known or suspected abnormality of pelvic organs

4.99

5.44

7.9

6.9

—

Prolonged pregnancy

5.29

5.40

6.7

—

Other obstetric conditions, not elsewhere classified

2.74

5.02

6.8

6.7

—

Persons with potential health hazards related to communicable diseases

2.94

4.89

7.5

6.3

—

Maternal care for known or suspected malpresentation of fetus

4.56

4.32

7.1

6.9

—

Contact with and exposure to communicable diseases

2.83

4.18

8.1

6.5

—

Complications predominantly related to the puerperium

3.00

3.68

6.7

7.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.44

3.64

7.3

6.7

—

Perineal laceration during delivery

3.13

3.34

9.1

5.4

—

Infections of breast associated with childbirth

8.60

3.26

8.8

5.7

—

Gestational diabetes (for exclusion)

2.32

2.99

6.2

7.0

—

Postpartum haemorrhage

2.90

2.73

7.3

5.2

—

Tramadol

0.00

2.69

0.0

8.1

—

Placenta praevia

7.16

2.55

7.4

9.3

—

Spontaneous abortion

2.31

2.54

7.5

6.5

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.00

2.53

0.0

8.0

—

Diabetes, insulin treatment (Kela reimbursement)

0.00

2.53

0.0

8.1

—

Obstructed labour due to malposition and malpresentation of fetus

2.86

2.27

8.0

5.2

—

First line medication for Crohn's disease

0.32

2.26

8.2

6.6

—

ILD medications: immunosuppressive drugs

0.00

2.23

0.0

7.2

—

Superficial injury of forearm

4.29

2.15

4.7

8.0

—

Inflammatory bowel disease treatment related agents

0.33

2.11

8.2

6.6

—

Obesity due to excess calories

2.32

2.04

4.2

7.2

—

Abnormal findings on antenatal screening of mother

3.08

2.01

5.9

7.8

—

Haemorrhage in early pregnancy

2.64

2.00

5.3

7.5

—

Maternal care for known or suspected fetal abnormality and damage

3.46

2.00

12.9

6.9

—

Opioids

0.36

2.00

2.0

6.9

—

Preterm labour and delivery

3.33

1.96

9.0

6.4

—

Atopic dermatitis

2.04

1.94

5.8

6.8

—

Effects of foreign body entering through natural orifice

3.53

1.83

4.0

7.1

—

Other nutritional deficiencies

2.06

1.81

5.5

6.9

—

Long labour

2.50

1.78

7.6

5.3

—

Codeine or tramadol medication

0.39

1.72

2.0

7.0

—

Codeine

0.39

1.72

2.0

7.0

—

L04AX Other immunosuppressants

0.00

1.70

0.0

7.6

—

Dermatitis and eczema

1.85

1.68

6.0

6.8

—

Examination and observation for other reasons

2.14

1.56

7.8

6.0

—

Intestinal infectious diseases

1.84

1.56

4.6

7.0

—

Persons encountering health services for specific procedures and health care

0.39

1.55

5.4

6.7

—

Other disorders of skin and subcutaneous tissue

0.00

1.53

0.0

7.6

—

Generalized anxiety disorder

0.00

1.49

0.0

7.1

—

Reimbursement for rheumatic diseases

0.00

1.49

0.0

7.4

—

Obesity

1.93

1.44

4.1

7.1

—

Obesity and other hyperalimentation

1.92

1.44

4.1

7.1

—

All influenza

2.94

1.36

7.0

7.6

—

Insulin medication

0.00

1.35

0.0

8.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

0.00

1.35

0.0

8.0

—

Peritonsillar abscess

0.00

1.34

0.0

7.3

—

Melanocytic naevi

0.00

1.34

0.0

7.7

—

Cholecystectomy

0.00

1.33

0.0

7.6

—

Gestational [pregnancy-induced] hypertension

2.03

1.32

6.4

7.1

—

Leiomyoma of uterus

0.00

1.22

0.0

6.0

—

Infections of genitourinary tract in pregnancy

2.63

1.21

5.0

8.2

—

Leiomyoma of uterus

0.00

1.21

0.0

6.4

—

Antihypertensive medication - note that there are other indications

0.51

1.20

6.6

6.5

—

Psychiatric diseases

0.49

1.16

6.4

6.8

—

Any mental disorder

0.49

1.16

6.4

6.8

—

Emotionally unstable personality disorder

0.00

1.16

0.0

7.8

—

Cough

0.00

1.15

0.0

6.1

—

Melanocytic naevi

0.00

1.14

0.0

7.9

—

Maternal care for other conditions predominantly related to pregnancy

2.02

1.13

8.1

7.3

—

Poor fetal growth

2.00

1.12

6.0

7.3

—

Abnormalities of breathing

0.48

1.09

3.5

6.5

—

Pregnancy with abortive outcome

1.63

1.07

6.4

6.5

—

Postpartum hemorraghe, all women as controls

1.81

1.07

7.3

6.8

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.75

1.03

5.8

6.9

—

Insulin, intermediate and long-acting

0.00

0.97

0.0

7.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

0.00

0.97

0.0

7.9

—

Keratitis

0.00

0.97

0.0

7.4

—

In situ neoplasms

0.00

0.96

0.0

7.3

—

Infections of the skin and subcutaneous tissue

1.76

0.94

3.7

7.8

—

Symptoms and signs involving the digestive system and abdomen

0.51

0.88

4.3

7.1

—

Pregnancy hypertension

1.66

0.83

5.9

6.9

—

Diseases of the skin and subcutaneous tissue

1.53

0.82

5.7

7.2

—

Internal derangement of knee

1.87

0.81

6.0

7.7

—

Injuries to the elbow and forearm

1.64

0.80

7.7

6.5

—

Acute bronchitis

1.84

0.80

4.8

8.0

—

Sub-endpoint used in defining T1D endpoints

0.00

0.79

0.0

6.9

—

Other sexually transmitted chlamydial diseases

0.00

0.79

0.0

8.0

—

Speech and linguistic disorders, excluding more controls

0.00

0.79

0.0

7.9

—

Sulfasalazine

0.00

0.79

0.0

6.2

—

Female infertility, associated with anovulation

1.82

0.79

7.3

8.0

—

Amenorrhoea

0.00

0.79

0.0

8.0

—

Carcinoma in situ of cervix uteri

0.00

0.79

0.0

7.2

—

Dental caries 2 and operation codes

1.55

0.79

7.2

6.5

—

Fracture of foot, except ankle

0.00

0.78

0.0

8.4

—

Insulin, fast-acting or short human

0.00

0.78

0.0

7.0

—

Insulin, fast-acting

0.00

0.78

0.0

7.0

—

Other problems related to primary support group, including family circumstances

0.00

0.78

0.0

8.6

—

Erosion of teeth, including avohilmo

0.00

0.77

0.0

6.9

—

Acne vulgaris

0.00

0.77

0.0

7.5

—

Carcinoma in situ of cervix uteri

0.00

0.77

0.0

7.3

—

Unspecified/other endometriosis

0.00

0.77

0.0

7.0

—

LSIL lesion of the cervix uteri

0.00

0.77

0.0

7.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.77

0.0

7.0

—

Adverse effects, not elsewhere classified

0.00

0.77

0.0

8.3

—

Diseases of the digestive system

0.00

0.77

0.0

7.7

—

Dental caries 2, only avohilmo

1.54

0.77

7.2

6.5

—

Autoimmune diseases excluding thyroid diseases

0.58

0.77

6.3

6.8

—

Dental caries 2 and operation codes, only avohilmo

1.55

0.76

7.2

6.5

—

Disorders of psychological development

0.00

0.76

0.0

7.6

—

In situ neoplasms

0.00

0.76

0.0

7.2

—

Type 1 diabetes

0.00

0.76

0.0

8.4

—

Dental caries 2

1.53

0.76

7.2

6.5

—

Polycystic ovarian syndrome, consortium definition

0.57

0.75

5.8

6.7

—

Anxiety disorders, excluding more controls

0.55

0.74

6.7

6.8

—

Pneumonias (Asthma/COPD co-morbidities)

0.55

0.74

5.0

6.9

—

Bronchitis

1.49

0.74

5.5

6.8

—

All pneumoniae

0.54

0.74

5.0

6.8

—

Any reimbursement code in KELA

0.61

0.73

9.2

6.0

—

Intracranial injury

1.58

0.71

7.8

6.6

—

Nerve, nerve root and plexus disorders

0.52

0.69

4.0

7.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

0.59

0.66

6.3

6.6

—

Excessive, frequent and irregular menstruation

0.58

0.65

3.0

7.2

—

Diseases of oesophagus, stomach and duodenum

0.58

0.64

3.7

7.2

—

Type of accident

1.72

0.64

3.8

7.9

—

Other diseases of intestines

0.64

0.63

3.8

7.0

—

Arthrosis

0.00

0.62

0.0

7.3

—

Cystitis

1.42

0.61

4.2

7.4

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.67

0.61

3.8

8.3

—

Accidents

1.47

0.61

8.5

6.9

—

Abdominal and pelvic pain

0.60

0.61

4.3

7.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.51

0.61

3.1

7.0

—

Bacterial infection, other or unspecified

0.00

0.61

0.0

7.3

—

Oxicams

0.00

0.60

0.0

9.6

—

Speech and linguistic disorders

0.00

0.60

0.0

8.8

—

Superficial injury of ankle and foot

0.00

0.60

0.0

9.1

—

Dental operations

1.81

0.60

8.0

6.3

—

Dental operations, only avohilmo

1.81

0.60

8.0

6.3

—

Non-invasive ventilation

0.00

0.60

0.0

8.9

—

Persistent mood disorders

0.00

0.60

0.0

7.3

—

Mood disorders, excluding more controls

0.59

8.4

6.8

—

Fracture of shoulder and upper arm

0.00

0.59

0.0

8.5

—

Other noninfective gastroenteritis and colitis

0.00

0.59

0.0

8.4

—

Type 1 diabetes, wide definition, subgroup 1

0.00

0.59

0.0

7.3

—

Dermatitis

1.54

0.59

5.1

7.4

—

Type 1 diabetes, wide definition

0.00

0.58

0.0

7.0

—

Pre-eclampsia or poor fetal growth

1.56

0.58

6.5

6.8

—

Female infertility

1.51

0.57

7.3

7.2

—

Cardiovascular diseases (excluding rheumatic etc)

0.64

0.57

3.3

7.1

—

Other complications of labour and delivery, not elsewhere classified

1.65

0.56

4.5

5.3

—

Mood [affective] disorders

0.63

0.56

7.8

6.6

—

Mood disorders

0.63

0.55

7.8

6.6

—

Abnormalities of heart beat

1.61

0.55

9.5

6.9

—

Diabetes medication

0.61

0.54

3.5

7.1

—

Diabetes, varying definitions

0.60

0.54

3.5

7.1

—

Diabetes mellitus

0.60

0.54

3.5

7.1

—

Other heart diseases, wide

0.61

0.54

5.3

7.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

0.61

0.53

5.0

6.8

—

0.61

0.53

5.0

6.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.60

0.53

5.0

7.1

—

Covid-19 suspected case

1.54

0.53

7.8

7.1

—

Endocrine, nutritional and metabolic diseases

1.37

0.52

4.8

7.1

—

Acute upper respiratory infections

1.40

0.52

6.3

7.0

—

Visual disturbances and blindness

1.50

0.51

4.2

7.4

—

Polycystic ovarian syndrome, broad definition

1.56

0.49

6.4

7.0

—

Parasetamol

1.36

0.48

7.2

6.4

—

Chronic diseases of tonsils and adenoids

0.67

0.47

5.1

6.7

—

Tonsillectomy and adenotomy

0.68

0.47

5.1

6.7

—

Pneumonia, organism unspecified

0.60

0.46

5.4

7.2

—

Other disorders of urethra and urinary system

0.60

0.46

2.4

7.7

—

Embedded and impacted teeth

1.42

0.46

5.5

6.6

—

Depression

0.66

0.46

7.8

6.6

—

GASTRO-related operations

0.71

0.46

3.7

6.8

—

Any gastric operation

0.71

0.46

3.7

6.8

—

Fracture of forearm

1.42

0.45

10.1

6.6

—

Other headache syndromes

1.37

0.44

2.4

8.1

—

Strabismus

1.56

0.42

7.0

7.7

—

Transport accidents

1.39

0.42

8.3

6.9

—

Rheumatoid arthritis

0.00

0.41

0.0

6.0

—

Septicaemia

0.00

0.41

0.0

7.3

—

Inflammatory disease of uterus

1.52

0.41

2.4

8.1

—

Injuries to the neck

1.52

0.41

4.0

7.9

—

Dental caries

0.00

0.41

0.0

8.4

—

Azathioprine

0.00

0.41

0.0

7.5

—

Acute alcohol intoxication, ICD10

0.00

0.41

0.0

7.5

—

Tumor necrosis factor alpha inhibitors

0.00

0.41

0.0

7.8

—

ILD medications: azathioprine

0.00

0.41

0.0

7.3

—

Other female pelvic inflammatory diseases

0.00

0.41

0.0

6.5

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.41

0.0

7.1

—

Acute alcohol intoxication

0.00

0.41

0.0

7.3

—

Type 1 diabetes, definitions combined

0.00

0.41

0.0

7.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.50

0.41

3.2

8.0

—

Biological medication for rheuma

0.00

0.40

0.0

7.5

—

Rheumatoid arthritis, including avohilmo

0.00

0.40

0.0

6.9

—

Gingivitis and periodontal diseases

1.42

0.40

6.6

7.0

—

Conjunctivitis (acute, non atopic)

1.47

0.40

8.4

7.4

—

Striking against or struck by other objects

1.43

0.39

6.2

7.9

—

Diseases of oral cavity, salivary glands and jaws

1.41

0.39

5.9

7.0

—

Other and unspecified mood [affective] disorders

0.00

0.39

0.0

8.4

—

Alcohol abuse, main dg, excluding more controls

0.00

0.39

0.0

8.4

—

Substance use, excluding alcohol

0.00

0.39

0.0

7.0

—

Congenital malformations of genital organs

0.00

0.39

0.0

6.6

—

Acute sinusitis

1.35

0.38

8.6

7.2

—

Impacted teeth

1.33

0.37

5.6

6.7

—

Female infertility, cervigal, vaginal, other or unspecified origin

1.31

0.37

7.4

7.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.32

0.37

5.3

7.3

—

Diseases of the musculoskeletal system and connective tissue

0.73

0.37

6.7

7.3

—

Appendicitis, broad definition

0.63

0.35

3.6

7.1

—

Diseases of appendix

0.63

0.35

3.6

7.1

—

Ovarian cyst

0.65

0.34

4.5

7.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.37

0.33

5.1

7.4

—

Complications of surgical and medical care, not elsewhere classified

0.69

0.33

5.0

7.0

—

Autoimmune diseases related-to ILD

0.69

0.33

9.3

6.6

—

Renal tubulo-interstitial diseases

0.66

0.33

4.8

7.1

—

Medical observation and evaluation for suspected diseases and conditions

1.38

0.33

2.9

6.0

—

Falls/tendency to fall

1.25

0.32

7.3

6.4

—

Postpartum hemorraghe, parous women as controls

1.31

0.32

7.3

6.5

—

Other abnormal products of conception

1.36

0.31

5.1

6.7

—

Selective serotonin reuptake inhibitors

0.75

0.31

8.3

6.4

—

Other diseases of upper respiratory tract

0.76

0.31

5.8

6.7

—

Irregular menses

0.70

0.31

6.3

6.8

—

Asthma (diagnoses ohter than nonallergic)

0.70

0.30

6.3

6.6

—

1.26

0.29

6.3

6.4

—

Persons encountering health services for examination and investigation

1.35

0.29

8.2

6.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.28

0.28

5.8

6.8

—

Other external causes of accidental injury

1.28

0.27

8.2

6.9

—

Other diseases of urinary system

1.23

0.27

4.2

7.4

—

Dental pulpitis 3, only avohilmo

0.70

0.26

7.0

6.8

—

Triptan medication for migraine, single purchase ok

1.25

0.26

6.6

6.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.25

0.26

6.6

6.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.23

0.26

10.1

6.0

—

Exposure to other specified factors

1.27

0.25

5.2

6.9

—

Depression or dysthymia

0.73

0.25

5.3

6.5

—

Type 2 diabetes

0.71

0.25

3.5

7.8

—

Concussion

1.18

0.24

7.8

7.3

—

Neurological diseases, wide definition

1.28

0.24

6.7

7.8

—

Autoimmune diseases

0.81

0.24

5.9

6.8

—

Pain (limb, back, neck, head abdominally)

0.73

0.23

5.7

7.3

—

Asthma (only as main-diagnosis), excluding more controls

0.76

0.23

8.6

6.8

—

Dental pulpitis 4

0.81

0.23

7.1

6.4

—

Diseases of pulp and periapical tissues, including avohilmo

0.81

0.23

7.1

6.4

—

Dental pulpitis 1

0.81

0.23

7.1

6.4

—

Diseases of middle ear and mastoid

1.24

0.23

5.8

6.7

—

Diseases of the ear and mastoid process

0.81

0.23

6.7

6.5

—

Visual disturbances

1.28

0.23

4.0

7.6

—

Used for control exclusion in common control thyroid runs

0.81

0.22

5.9

6.6

—

Low back pain

0.76

0.22

5.4

7.3

—

Diabetic retinopathy, excluding more controls

0.00

0.22

0.0

3.5

—

Asthma, hospital admissions , main diagnosis only

0.74

0.22

8.6

6.4

—

Gonarthrosis

0.00

0.22

0.0

8.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.22

0.22

2.6

7.8

—

Asthma, excluding more controls

0.78

0.22

7.3

6.8

—

Asthma

0.78

0.22

7.3

6.8

—

STROKE

0.00

0.22

0.0

8.0

—

Dental caries 3 and operation codes

1.28

0.22

7.3

6.8

—

Urticaria

1.22

0.22

3.8

7.6

—

Other and unspecified dermatitis

1.22

0.22

6.0

7.8

—

Sciatica+with lumbago

1.22

0.22

2.6

8.4

—

Other degenerative diseases of the nervous system

0.00

0.22

0.0

8.0

—

Fall on same level

0.82

0.21

4.6

6.8

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

0.21

0.0

8.2

—

Other juvenile arthritis

0.00

0.21

0.0

7.9

—

Other obstetric trauma

0.00

0.21

0.0

7.6

—

Specific development disorders of scholastic skills

0.00

0.21

0.0

7.6

—

Other specified and unspecified personality disorders

0.00

0.21

0.0

7.8

—

Melanocytic naevi of trunk

0.00

0.21

0.0

8.1

—

Melanocytic naevi of trunk

0.00

0.21

0.0

8.1

—

Coeliac disease

0.00

0.21

0.0

8.1

—

Mucosal proctocolitis

0.00

0.21

0.0

7.5

—

Spondylopathies (FG)

0.00

0.21

0.0

7.8

—

Enlarged lymph nodes

0.00

0.21

0.0

8.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.21

0.0

7.5

—

Focal epilepsy, strict definition

0.00

0.21

0.0

7.5

—

Diseases of salivary glands

0.00

0.21

0.0

9.7

—

Vocal cord dysfunction

0.00

0.21

0.0

8.9

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.21

0.0

7.5

—

Alcohol abuse, main dg

0.00

0.21

0.0

8.2

—

Fracture of skull and facial bones

0.00

0.21

0.0

6.3

—

Enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

6.8

—

Fissure and fistula of anal and rectal regions

0.00

0.21

0.0

7.4

—

Colonic or urogenital fistula

0.00

0.21

0.0

7.4

—

Spondyloarthritis

0.00

0.21

0.0

7.6

—

Type1 diabetes, definitions combined, early onset

0.00

0.21

0.0

7.5

—

Excluding asthma or asthma-COPD overlap

0.80

0.21

9.4

6.8

—

Other pulmonary diagnosis

0.80

0.21

9.4

6.8

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.21

0.0

7.6

—

Hypertrophy of breast

0.00

0.21

0.0

7.2

—

Hypertrophy of breast in women and men

0.00

0.21

0.0

7.2

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.21

0.0

7.2

—

Type 1 diabetes, strict definition

0.00

0.21

0.0

7.2

—

Dentinal caries

0.00

0.20

0.0

8.5

—

Other septicaemia

0.00

0.20

0.0

7.3

—

Specific development disorders of speech and language

0.00

0.20

0.0

7.8

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

0.81

0.20

5.0

6.7

—

Abnormal findings on examination of blood, without diagnosis

0.00

0.20

0.0

7.5

—

Neurotic, stress-related and somatoform disorders

0.80

0.20

5.2

6.9

—

Anxiety disorders

0.80

0.20

5.2

6.9

—

Open wound of wrist and hand

1.26

0.20

5.7

7.2

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.20

0.0

7.1

—

Bitten or struck by other mammals

0.00

0.20

0.0

8.0

—

Allergic contact dermatitis

0.00

0.20

0.0

7.6

—

Insulin, fast-acting (human)

0.00

0.20

0.0

7.4

—

Corneal ulcer

0.00

0.20

0.0

7.3

—

Focal epilepsy

0.00

0.20

0.0

7.2

—

Congenital malformations and deformations of the musculoskeletal system

0.00

0.20

0.0

7.8

—

Acute bronchiolitis

0.00

0.20

0.0

6.8

—

Influenza and pneumonia

0.81

0.19

5.6

6.7

—

Other antidepressants

0.82

0.19

6.4

—

Medical treatment for female infertility

1.15

0.19

3.8

7.1

—

Hernia

1.22

0.18

6.1

7.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.19

0.18

9.4

6.2

—

Episodal and paroxysmal disorders

0.84

0.18

2.8

7.3

—

Headache

1.23

0.17

5.0

6.9

—

Medical abortion

1.20

0.17

7.7

6.6

—

Injuries to the shoulder and upper arm

1.15

0.17

4.6

7.0

—

Asthma, hospital admission 2, infections

1.15

0.17

6.3

6.6

—

Asthma-related infections

1.15

0.17

6.3

6.6

—

Soft tissue disorders

1.16

0.17

5.5

6.9

—

Injuries to the ankle and foot

1.21

0.17

4.9

6.8

—

Disorders of breast

0.76

0.17

4.8

7.1

—

Acute tubulo-interstitial nephritis

0.73

0.17

2.4

7.3

—

Acute suppurative otitis media

0.72

0.17

3.6

6.8

—

Dorsopathies

1.16

0.16

4.0

7.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.14

0.16

6.3

7.1

—

Provisional assignment of new diseases of uncertain etiology

1.16

0.16

7.1

6.8

—

Codes for special purposes

1.16

0.16

7.1

6.8

—

Childhood allergy (age < 16)

0.78

0.15

7.5

6.6

—

Injury, poisoning and certain other consequences of external causes

1.13

0.15

5.9

6.9

—

Appendectomy

0.78

0.15

3.5

7.0

—

Asthma (only as main-diagnosis)

0.77

0.15

8.6

6.8

—

Arthropathies

0.86

0.15

5.7

6.8

—

Noninflammatory disorders of female genital tract

0.84

0.14

8.1

7.1

—

Depression medications

0.82

0.14

10.4

6.6

—

Gastrointestinal diseases

0.85

0.14

5.7

7.1

—

Asthma (mode)

0.80

0.14

7.2

6.8

—

Injuries to the wrist and hand

1.16

0.14

4.8

6.8

—

COPD differential diagnosis

0.82

0.13

9.4

6.8

—

ILD differential diagnosis

0.82

0.13

9.4

6.8

—

Chronic lower respiratory diseases

0.87

0.13

7.1

6.5

—

Triptan medication for migraine, min. 3 purchases

0.84

0.13

6.2

6.6

—

Dental pulpitis 4, only avohilmo

0.87

0.13

7.2

6.3

—

Dental pulpitis 1, only avohilmo

0.87

0.13

7.2

6.3

—

Injuries to the head

1.14

0.12

6.6

6.5

—

Suppurative and unspecified otitis media

1.17

0.11

6.0

6.8

—

Cardiovascular diseases

0.89

0.10

5.7

6.8

—

Asthma/COPD (KELA code 203)

0.87

0.10

8.1

6.5

—

Other specific joint derangements/joint disorders

0.87

0.10

4.5

6.8

—

Viral and other specified intestinal infections

1.11

0.09

5.2

7.6

—

Urticaria and erythema

1.11

0.09

3.8

7.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.11

0.09

4.4

7.4

—

Migraine without aura

1.09

0.09

3.0

7.7

—

Unspecified mental disorder

1.04

0.09

3.8

7.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.12

0.09

4.0

6.0

—

Other joint disorders

1.11

0.09

5.3

6.8

—

Other acute lower respiratory infections

1.10

0.09

4.8

7.0

—

Propionic acid derivatives

0.81

0.08

7.0

7.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

0.76

0.08

5.0

6.6

—

Dizziness and giddiness

0.83

0.08

5.0

7.4

—

Postpartum haemorrhage due to anatomy

0.79

0.08

7.2

7.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

0.78

0.08

4.0

7.1

—

Dental caries 3, only avohilmo

1.05

0.08

7.4

6.9

—

Dental caries 3

1.05

0.08

7.4

6.9

—

General symptoms and signs

1.11

0.08

5.0

6.9

—

Type 2 diabetes, definitions combined

0.85

0.08

3.5

8.0

—

Type 2 diabetes, strict (exclude DM1)

0.85

0.08

3.5

8.0

—

Other (not insulin) diabetes medications

0.84

0.08

3.5

7.9

—

Type 2 diabetes, definitions combined, including avohilmo

0.83

0.08

3.5

7.9

—

Pain in joint

0.83

0.08

3.5

7.3

—

Cardiac arrhythmias

0.81

0.08

5.3

7.7

—

Dental pulpitis 3

0.81

0.07

6.0

6.8

—

Hypothyroidism, levothyroxine purchases

1.06

0.07

5.0

6.6

—

Hypothyroidism and >3 levothyroxin purchases

1.06

0.07

5.0

6.6

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.08

0.07

7.2

6.8

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.05

0.07

6.6

7.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.04

0.07

7.2

6.8

—

External causes of morbidity and mortality

1.12

0.07

10.0

7.0

—

Intracranial trauma

1.02

0.07

7.8

7.3

—

Hypothyroidism, strict autoimmune

0.86

0.06

5.0

6.7

—

Acute upper respiratory infections of multiple and unspecified sites

1.12

0.06

5.4

7.0

—

Injuries to the knee and lower leg

1.09

0.06

4.3

7.0

—

Disorders of the thyroid gland

0.92

0.04

7.0

6.7

—

Asthma, including avohilmo

0.93

0.03

6.8

6.5

—

Symptoms and signs involving the circulatory and respiratory systems

0.94

0.03

8.3

6.5

—

Persons encountering health services in other circumstances, wide

0.93

0.03

10.6

6.2

—

1.07

0.03

7.4

6.7

—

Dorsalgia

0.94

0.02

3.5

7.1

—

Certain infectious and parasitic diseases

0.94

0.02

6.3

7.1

—

Other dorsopathies, not elsewhere classified

1.05

0.02

3.3

7.1

—

Other soft tissue disorders, not elsewhere classified

1.06

0.01

6.2

6.9

—

Neurological diseases

0.95

0.01

3.0

7.5

—

Disorders of conjunctiva

1.00

0.00

7.2

6.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.05

0.00

7.0

6.5

—

Diseases of the eye and adnexa

0.99

0.00

6.6

—

COPD/asthma related infections

0.95

0.00

6.9

6.8

—

COPD/asthma/ILD related infections

0.95

0.00

6.9

6.8

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.95

0.00

6.5

6.7

—

Lower back pain or/and sciatica

0.95

0.00

4.3

6.9

—

Hypothyroidism, other/unspecified

0.97

0.00

6.5

6.7

—

Exposure to unspecified factor

1.03

0.00

4.0

6.9

—

Inflammatory diseases of female pelvic organs

1.05

0.00

4.8

7.0

—

Superficial injury of hip and thigh

0.00

0.0

8.1

—

Etanercept

0.00

0.0

8.0

—

Nasal polyp

0.00

0.0

7.6

—

Early lumbar disc prolapse, operated

0.00

0.0

7.6

—

Other and unspecified coagulation defects

0.00

0.0

8.0

—

Congenital malformations of uterus and cervix

0.00

0.0

8.0

—

Noninfectious colitis NAS

0.00

0.0

8.8

—

Astigmatism

0.00

0.0

8.5

—

Effects of other external causes

0.00

0.0

7.4

—

Other diseases of jaws

0.00

0.0

14.4

—

Autism spe, excluding more controls

0.00

0.0

8.1

—

Endometriosis of rectovaginal septum and vagina

0.00

0.0

7.1

—

DVT of lower extremities and pulmonary embolism

0.00

0.0

9.9

—

Other reaction to severe stress, and adjustment disorders

0.87

0.00

3.8

7.2

—

Disorders of lipoprotein metabolism and other lipidaemias

0.00

0.0

8.0

—

Diabetic retinopathy, strict definition

0.00

0.0

3.5

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

0.0

8.0

—

Pruritus

0.00

0.0

7.4

—

Chronic iridocyclitis

0.00

0.0

9.0

—

GI-bleeding

0.00

0.0

7.4

—

Certain disorders involving the immune mechanism

0.00

0.0

8.0

—

Benign neoplasm of ovary

0.00

0.0

8.0

—

Heart failure, not strict

0.00

0.0

8.0

—

Abnormalities of gait and mobility

0.00

0.0

9.0

—

Zoster [herpes zoster]

0.00

0.0

8.0

—

Diagnoses used for exclusion with ILD

0.00

0.0

8.0

—

Benign neoplasm of bone and articular cartilage

0.00

0.0

8.0

—

Schizophrenia

0.00

0.0

8.0

—

TMD related pain

0.00

0.0

8.0

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.0

8.0

—

Viral meningitis

0.00

0.0

8.6

—

Other surgical follow-up care

0.00

0.0

9.0

—

Open wound of lower leg

0.00

0.0

11.9

—

General examination and investigation of persons without complaint and reported diagnosis

1.01

0.00

7.1

6.0

—

Hypothyroidism (congenital or acquired)

0.94

0.00

5.4

6.6

—

Benign neoplasm of bone and articular cartilage

0.00

0.0

8.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

0.0

8.0

—

Tinnitus

0.00

0.0

8.0

—

Dental caries 1

0.88

0.00

8.0

7.2

—

Implicit bacterial Sepsis

0.00

0.0

8.0

—

Malignant neoplasm of skin

0.00

0.0

6.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.91

0.00

4.0

7.4

—

Diseases of liver

0.00

0.0

7.7

—

Other and unspecified injuries of lower leg

0.00

0.0

11.8

—

Direct fill therapy

0.00

0.0

8.1

—

Intentional self-harm by sharp object

0.00

0.0

8.0

—

Gonarthrosis [arthrosis of knee](FG)

0.00

0.0

8.6

—

Extrapyramidal and movement disorders

0.00

0.0

9.6

—

Cyst of Bartholin Gland

0.00

0.0

6.2

—

Other disorders of teeth and supporting structures

0.00

0.0

10.4

—

Allergic purpura

0.00

0.0

9.0

—

Lactose intolerance

0.00

0.0

9.0

—

Disorders of vitreous body and globe

0.00

0.0

8.0

—

Chronic suppurative otitis media

0.00

0.0

8.7

—

Glomerular disorders in diseases classified elsewhere

0.00

0.0

6.2

—

Lack of expected normal physiological development

0.00

0.0

8.7

—

Acute and transient psychotic disorders

0.00

0.0

8.0

—

Mental and behavioural disorders due to cannabinoids

0.00

0.0

8.0

—

Disorders of tooth development and eruption

0.00

0.0

9.8

—

Intestinal stricture

0.00

0.0

6.2

—

Dental pulpitis 2, only avohilmo

0.95

0.00

8.0

7.5

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

8.0

—

Wide developmental disorders

0.00

0.0

9.3

—

Mixed disorders of conduct and emotions

0.00

0.0

9.9

—

Autism spe

0.00

0.0

8.6

—

Maxillary retrognathism

0.00

0.0

6.2

—

Hypertrophic disorders of skin

0.00

0.0

9.9

—

Benign mammary dysplasia

0.00

0.0

8.0

—

Ingrowing nail

0.00

0.0

8.2

—

Dental caries, including avohilmo

0.88

0.00

8.0

7.2

—

Rosacea

0.00

0.0

8.2

—

Lichen planus, including avohilmo

0.00

0.0

8.0

—

Ankylosing spondylitis, ICD10

0.00

0.0

8.0

—

Ovarian hyperstimulation (induction)

0.00

0.0

6.2

—

Early lumbar disc prolapse operation

0.00

0.0

7.5

—

Other inflammation of vagina/vulva

0.00

0.0

8.0

—

Recurrent dislocation and subluxation of joint

0.00

0.0

8.6

—

Other disorders of fluid, electrolyte and acid-base balance

0.00

0.0

8.0

—

Complications associated with artificial fertilization

0.00

0.0

7.6

—

Non-selective monoamine reuptake inhibitors

0.00

0.0

6.5

—

Urolithiasis

0.00

0.0

8.0

—

Valvular heart disease excluding rheumatic fever

0.00

0.0

8.2

—

Genitourinary diseases

0.91

0.00

9.8

7.7

—

LeFortI or BSSRO operation

0.00

0.0

8.0

—

Correction of physiology of bite - demanding therapy visit

0.00

0.0

7.0

—

Viral hepatitis, IBD co-morbidity

0.00

0.0

6.5

—

Dental caries 1 and operation codes

1.00

0.00

7.4

6.9

—

Dental caries 1, only avohilmo

0.88

0.00

8.0

7.2

—

Other chronic obstructive pulmonary disease, including avohilmo

0.00

0.0

6.2

—

Certolizumab pegol

0.00

0.0

8.0

—

Bilateral sagittal split ramus osteotomy operation

0.00

0.0

8.0

—

Hypertrophic scar

0.00

0.0

8.0

—

Other gastritis (incl. Duodenitis)

0.00

0.0

8.0

—

L04AA Selective immunosuppressants

0.00

0.0

8.0

—

Dental pulpitis 2

0.98

0.00

8.0

7.8

—

Adalimumab

0.00

0.0

7.0

—

Oxycodone

0.00

0.0

6.2

—

Use of pramipexole

0.00

0.0

6.2

—

Psoriatic and enteropathic arthropathies

0.00

0.0

8.6

—

Congenital deformities of feet

0.00

0.0

7.4

—

Congenital malformations, deformations and chromosomal abnormalities

0.89

0.00

4.4

6.8

—

Congenital malformations of breast

0.00

0.0

8.0

—

Other skin changes

0.00

0.0

8.0

—

Abnormal findings on diagnostic imaging of central nervous system

0.00

0.0

8.2

—

Polyuria

0.00

0.0

7.0

—

Other/unspecified reactive arthropathies

0.00

0.0

8.0

—

Rash and other nonspecific skin eruption

0.00

0.0

8.0

—

Elevated blood glucose level

0.00

0.0

9.0

—

Diseases of the respiratory system

0.98

0.00

6.2

7.1

—

Pain in throat and chest

0.93

0.00

6.0

6.5

—

Hypoplasia of dental enamel , including avohilmo

0.00

0.0

11.8

—

Pulmonary heart disease, diseases of pulmonary circulation

0.00

0.0

8.0

—

Sequelae of injuries of upper limb

0.00

0.0

9.0

—

Unspecified urinary incontinence

0.00

0.0

9.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.0

8.0

—

Contusion of ankle

0.00

0.0

9.9

—

Complications of procedures, not elsewhere classified

0.89

0.00

5.0

7.2

—

Other and unspecified injuries of wrist and hand

0.00

0.0

8.6

—

Contusion of toe(s) without damage to nail

0.00

0.0

9.0

—

Contusion of other and unspecified parts of foot

0.00

0.0

8.8

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.0

8.2

—

Allergic asthma (mode), excluding more controls

0.93

0.00

4.2

6.8

—

Other CVD

0.00

0.0

9.0

—

Benign neoplasm of breast

0.00

0.0

8.0

—

Open wound of forearm

0.00

0.0

9.9

—

Other complications of surgical and medical care, not elsewhere classified

0.00

0.0

8.2

—

Event of undetermined intent

0.00

0.0

8.0

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.0

8.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

0.0

8.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.0

8.0

—

Viral pneumonia (unknown virus, not influenza)

0.00

0.0

8.0

—

Exposure to other and unspecified animate mechanical forces

0.00

0.0

9.0

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.0

8.0

—

Assault by bodily force

0.00

0.0

7.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

0.0

8.0

—

Pedestrian injured in transport accident

0.00

0.0

6.2

—

Misadventures to patients during surgical and medical care

0.00

0.0

8.0

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

0.0

8.0

—

Desensitization to allergens

0.00

0.0

8.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

0.0

6.2

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.0

8.8

—

Car occupant injured in noncollision transport accident

0.00

0.0

8.0

—

Other and unspecified drugs and medicaments

0.00

0.0

6.2

—

Chronic suppurative otitis media, including avohilmo

0.00

0.0

7.6

—

Family history of malignant neoplasm

0.00

0.0

7.4

—

Otalgia

0.00

0.0

7.0

—

Presence of other devices

0.00

0.0

8.6

—

Persons encountering health services for specific procedures, not carried out

0.00

0.0

6.5

—

Conductive hearing loss, unspecified

0.00

0.0

8.0

—

0.00

0.0

8.1

—

Benign lipomatous neoplasm

0.00

0.0

8.0

—

Other congenital malformations of face and neck

0.00

0.0

8.6

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

8.0

—

Benign neoplasm of mouth and pharynx

0.00

0.0

8.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

8.6

—

Melanocytic naevi of other and unspecified parts of face

0.00

0.0

8.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

8.0

—

Benign neoplasm of eye and adnexa

0.00

0.0

6.2

—

Benign neoplasm of ovary

0.00

0.0

8.0

—

Chronic viral hepatitis

0.00

0.0

8.0

—

Behavioural disorders, excluding more controls

0.00

0.0

9.9

—

Schizoaffective disorder

0.00

0.0

8.0

—

Wide developmental disorders, excluding more controls

0.00

0.0

8.1

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.00

0.0

6.2

—

Disorders of lens

0.00

0.0

6.2

—

Demyelinating diseases of the central nervous system

0.00

0.0

8.0

—

Other and unspecified visual disturbances

0.00

0.0

8.6

—

Pain in limb

0.90

0.00

5.3

6.8

—

Other osteochondropathies

0.00

0.0

8.0

—

Transient ischemic attack

0.00

0.0

6.2

—

Other chronic obstructive pulmonary disease

0.00

0.0

6.2

—

Other diseases of the digestive system

0.00

0.0

7.4

—

Benign neoplasm of eye and adnexa

0.00

0.0

6.2

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.0

8.0

—

Reactive arthropathies, FINNGEN

0.00

0.0

8.6

—

Hyperprolactinaemia

0.00

0.0

8.0

—

Melanocytic naevi of lower limb, including hip

0.00

0.0

6.2

—

Glomerular diseases

0.00

0.0

8.0

—

Conjunctivitis

0.93

0.00

7.6

6.5

—

Disorders of continuity of bone

0.00

0.0

8.0

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.0

9.9

—

Mental and behavioural disorders due to opioids

0.00

0.0

8.0

—

Cerebral cysts

0.00

0.0

8.0

—

Pulmonary heart disease

0.00

0.0

8.0

—

Glomerulonephritis

0.00

0.0

8.0

—

Undetermined asthma

0.00

0.0

8.4

—

Stroke, including SAH

0.00

0.0

8.0

—

Exposure to other and unspecified inanimate mechanical forces

0.00

0.0

9.0

—

Disorders of optic nerve and visual pathways

0.00

0.0

8.0

—

Mental and behavioural disorders due to tobacco

0.00

0.0

8.0

—

Other inflammation of eyelid

0.00

0.0

8.0

—

Toxic effect of ethanol

0.00

0.0

7.3

—

Dermatographic urticaria

0.00

0.0

8.0

—

FESS (DNB20)

0.00

0.0

8.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.0

8.0

—

Flat foot [pes planus] (acquired)

0.00

0.0

8.6

—

Intestinal malabsorption

0.00

0.0

9.0

—

Vitamin deficiency, wide

0.00

0.0

8.6

—

Mandibular retrognathia

0.00

0.0

7.0

—

Cerebral palsy and other paralytic syndromes

0.00

0.0

8.0

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

8.0

—

Hypopituitarism

0.00

0.0

6.2

—

Disorders of speech understanding and production

0.00

0.0

9.0

—

Tobacco use

0.00

0.0

8.0

—

Conduct disorder

0.00

0.0

10.7

—

Cerebrovascular diseases (FINNGEN)

0.00

0.0

8.2

—

Melanocytic naevi of lower limb, including hip

0.00

0.0

6.2

—

Vitamin deficiency

0.00

0.0

8.6

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

0.0

8.0

—

Ischemic heart diseases

0.00

0.0

8.0

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

8.0

—

Sleep disorders, other/unspecified

0.00

0.0

8.0

—

Seropositive rheumatoid arthritis

0.00

0.0

8.6

—

Undetermined asthma, excluding more controls

0.00

0.0

8.4

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.0

8.0

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

0.0

9.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.0

8.0

—

Unspecified privation

0.00

0.0

8.0

—

Cerebrovascular diseases

0.00

0.0

8.0

—

Crohn's disease of large intestine

0.00

0.0

6.2

—

Atopic dermatitis, strict definition

0.92

0.00

7.3

6.7

—

Agoraphobia

0.00

0.0

8.8

—

L04AD Calcineurin inhibitors

0.00

0.0

8.0

—

Burn and corrosion of wrist and hand

0.00

0.0

9.0

—

Other demyelinating diseases of the central nervous system

0.00

0.0

6.2

—

Deviated nasal septum

0.00

0.0

8.0

—

Inflammatory diseases of the central nervous system

0.00

0.0

6.2

—

Lesion of ulnar nerve

0.00

0.0

6.2

—

Autism

0.00

0.0

8.6

—

Hypertrichosis

0.00

0.0

8.2

—

Mixed and other personality disorders

0.00

0.0

8.0

—

Implicit Sepsis

0.97

0.00

3.4

7.4

—

Other keratitis

0.00

0.0

7.5

—

Mental retardation, excluding more controls

0.00

0.0

6.2

—

Abscess of anal and rectal regions

0.00

0.0

9.0

—

Other and unspecified tonsillitis

0.93

0.00

5.0

6.9

—

Viral pneumonia

0.00

0.0

8.0

—

Molar incisor enamel hypoplasia

0.00

0.0

11.8

—

Non-rheumatic valve diseases

0.00

0.0

8.2

—

Cluster headache, wide,, including avohilmo

0.00

0.0

6.2

—

Ethmoidectomy

0.00

0.0

8.0

—

Crossbite

0.00

0.0

9.0

—

Diabetic retinopathy

0.00

0.0

3.5

—

Convergent concomitant strabismus

0.00

0.0

8.5

—

Lactose intolerance, other/unspecified

0.00

0.0

9.0

—

Volume depletion

0.00

0.0

6.2

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.0

8.0

—

Stomatitis and related lesions

0.00

0.0

8.3

—

Hypoglycaemia, other or unspecified

0.00

0.0

8.0

—

Seropositive rheumatoid arthritis, wide

0.00

0.0

8.0

—

Other diseases of liver

0.00

0.0

6.2

—

Bell's palsy

0.00

0.0

8.0

—

Smoking dependency

0.00

0.0

8.0

—

Diabetic nephropathy, excluding more controls

0.00

0.0

3.8

—

Hard cardiovascular diseases

0.00

0.0

8.0

—

Dermatophytosis

0.00

0.0

8.0

—

Cluster headache, strict, including avohilmo

0.00

0.0

6.2

—

Purpura and other haemorrhagic conditions

0.00

0.0

8.0

—

Glaucoma

0.00

0.0

8.0

—

Calculus of kidney and ureter

0.00

0.0

8.0

—

Anxious personality disorder

0.00

0.0

9.0

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.0

8.2

—

Migraine

0.97

0.00

3.0

7.3

—

Hirsutism in women

0.00

0.0

8.2

—

Benign neoplasm of breast

0.00

0.0

8.0

—

Congenital malformations of the nervous system

0.00

0.0

6.2

—

Pulmonary embolism

0.00

0.0

8.0

—

Unspecified acute lower respiratory infection

0.00

0.0

8.0

—

severe traumatic brain injury, does not include concussion

0.00

0.0

8.0

—

Other disorders of eyelid

0.00

0.0

8.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.83

0.00

2.6

7.5

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.0

8.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

8.6

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.0

8.0

—

Disorders of vitreous body

0.00

0.0

8.0

—

Generalized epilepsy

0.00

0.0

8.0

—

Renal failure

0.00

0.0

8.0

—

Sacroiliitis, not elsewhere classified

0.00

0.0

5.8

—

Other ulcerative colitis

0.00

0.0

9.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

8.0

—

Other infectious diseases

0.00

0.0

9.0

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

0.0

8.2

—

Allergic asthma (mode)

0.93

0.00

4.2

6.8

—

Melanocytic naevi of other and unspecified parts of face

0.00

0.0

8.0

—

Benign neoplasm of mouth and pharynx

0.00

0.0

6.2

—

Stroke, excluding SAH

0.00

0.0

8.6

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

8.0

—

Retention of urine

0.00

0.0

8.0

—

Disorders of other endocrine glands

0.96

0.00

2.8

7.1

—

Collagenous colitis

0.00

0.0

8.0

—

Other follicular disorders

0.00

0.0

8.2

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

0.00

0.0

6.2

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

0.00

0.0

8.0

—

Restless leg syndrome

0.00

0.0

9.0

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

0.00

0.0

6.2

—

Pure hypercholesterolaemia

0.00

0.0

8.0

—

Deep endometriosis

0.00

0.0

7.5

—

COPD

0.00

0.0

6.2

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

6.2

—

Malignant neoplasm of breast

0.00

0.0

6.2

—

Methotrexate

0.00

0.0

8.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.0

8.0

—

Nontoxic multinodular goitre

0.00

0.0

6.2

—

Female infertility, tubal origin

0.00

0.0

7.7

—

Viral infections of the central nervous system

0.00

0.0

8.0

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

0.00

0.0

6.2

—

Nonspecific lymphadenitis

0.00

0.0

8.0

—

Malignant neoplasm of breast, HER2-negative

0.00

0.0

6.2

—

Benign paroxysmal vertigo

0.00

0.0

7.0

—

Biguanides

0.92

0.00

3.5

7.9

—

Ulcer of vagina/vulva

0.00

0.0

6.2

—

Nonalcoholic fatty liver disease

0.00

0.0

6.2

—

Glaucoma suspect

0.00

0.0

8.0

—

Varicella [chickenpox]

0.00

0.0

8.0

—

Nail disorders

0.00

0.0

8.2

—

Dermatitis due to substances taken internally

0.00

0.0

7.3

—

Paralytic ileus and intestinal obstruction

0.00

0.0

8.0

—

Atopic dermatitis, strict definition with reimbursement

0.92

0.00

7.3

7.0

—

Optic neuritis

0.00

0.0

8.0

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.0

7.0

—

Herpesviral [herpes simplex] infections

0.00

0.0

6.5

—

Reactive arthropathies

0.00

0.0

8.6

—

Pilonidal cyst

0.00

0.0

8.2

—

Juvenile arthritis (FINNGEN)

0.00

0.0

6.1

—

Mixed specific developmental disorders

0.00

0.0

8.2

—

Other viral hepatitis

0.00

0.0

8.0

—

Viral hepatitis

0.00

0.0

8.0

—

Other Crohn's disease

0.00

0.0

7.0

—

Atrophic disorders of skin

0.00

0.0

8.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.0

7.0

—

Other hearing loss

0.00

0.0

8.0

—

Agranulocytosis

0.00

0.0

6.2

—

Other and unspecified rosacea

0.00

0.0

8.2

—

Other diseases of blood and blood-forming organs, wide

0.00

0.0

9.9

—

Seborrhoeic dermatitis

0.00

0.0

8.6

—

Chronic gastritis

0.00

0.0

6.2

—

MS-disease / Multiple Sclerosis

0.00

0.0

8.0

—

Other arthrosis

0.00

0.0

8.6

—

Other (seronegative) rheumatoid arthritis, wide

0.00

0.0

8.0

—

Other congenital malformations of ear

0.00

0.0

9.0

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.0

6.2

—

Bacterial, viral and other infectious agents

0.00

0.0

8.0

—

Dermatitis due to ingested food

0.00

-0.00

0.0

7.5

—

Benign lipomatous neoplasm

0.00

-0.00

0.0

8.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

9.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

9.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bacteria [#/volume] in Mother's milk

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS